Latest / Clinical Capsules - Actionable Medication Pearls in Minutes
Lenacapavir for HIV Pre-Exposure Prophylaxis (PrEP)
In this episode, Rachel Cole, PharmD, explores the evolving landscape of medications for HIV pre-exposure prophylaxis (PrEP), spotlighting lenacapavir (Yeztugo)—a newly approved long-acting injectable option given just twice yearly.
She walks through how it compares to oral therapies like Truvada and Descovy, plus other injectables such as cabotegravir. Rachel also offers practical guidance on identifying candidates for HIV PrEP, navigating lab requirements, and managing side effects.
You’ll also hear strategies to help patients overcome cost barriers, improve adherence, and understand the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.